openPR Logo
Press release

Sepsis Diagnostics Market: Opportunities & Challenges

11-14-2019 09:40 AM CET | Health & Medicine

Press release from: MarketsandMarkets

Sepsis Diagnostics Market

Sepsis Diagnostics Market

The Global Sepsis Diagnostics Market is estimated to reach USD 613.9 million by 2023 from USD 396.6 billion in 2018, at a CAGR of 9.1% from 2018 to 2023.

The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis across the globe. Factors such as the rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and the commercialization and availability of a wide variety of approved sepsis diagnostic devices are also supporting the growth of this market. However, lack of established reimbursement policies for sepsis and the high cost of automated diagnostic devices are the major factors restraining the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=92673155

OPPORTUNITIES:

Development of rapid diagnostic/POC techniques for early sepsis diagnosis;

Sepsis is a very difficult condition to diagnose as the clinical presentation of sepsis is highly variable depending on etiology. Once the infection sets in, the condition of a patient deteriorates rapidly owing to which early diagnosis is a major area of focus in this market. Mortality rates from sepsis range between 40% to 70% for septic shock and 25% to 30% for severe sepsis (Source: Am Fam Physician. 2013 Jul 1; 88(1):44-53.). Early goal-directed therapy completed within the first six hours of sepsis diagnosis significantly reduces in-hospital mortality. Moreover, early antibiotic therapy helps in improving the clinical outcomes, which leads to improvement in sepsis outcomes, as the risk of mortality increases by 7.6% with a delay of even 1 minute in antibiotic administration in septic shock patients having hypertension. As a result, slower turnaround times of conventional/manual blood culture methods have created a demand for rapid diagnostic techniques providing faster results. The turnaround time of a conventional/manual blood culture method is more than 24 hours. On the other hand, fully automated blood culture systems offer faster turnaround times (4-6 hours) and also reduce labor costs. In addition, these automated systems can be used for large-scale sample handling and easier processing of challenging specimens.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=92673155

CHALLENGES:

Lack of standard protocols and awareness for sepsis diagnosis and treatment;

Lack of consensus on the clinical definition of sepsis and low awareness about sepsis among doctors and nurses is a major challenge in this market. Most physicians do not have an adequate understanding of sepsis as its symptoms are similar to other disease conditions; this often leads to incorrect or delayed examination and diagnosis of sepsis. According to a survey conducted among EMS professionals, awareness among these professionals is less than 10% in pre-hospital providers, who require sufficient knowledge to handle sepsis-focused scenarios. This is due to lack of pre-hospital sepsis dispatch and clinical care protocols across various regions (Source: Prehosp Disaster Med. 2013;28:104–6. doi: 10.1017/S1049023X12001744). Moreover, the protocols set for sepsis diagnosis are often impractical to implement; in some cases, the protocols are too detailed to understand the eventualities, whereas, in other cases, they suggest resources, which are unavailable locally. In 2015, according to a survey conducted by the UK Sepsis Trust, only 16% of the community was aware that sepsis was a time-critical medical condition. These findings mirror similar surveys conducted in Germany and the US. Similarly, according to a survey conducted for the Sepsis Alliance only 44% of the Americans had heard of sepsis.

Sepsis diagnosis is a difficult process due to a lack of appropriate standard protocols for the identification of this clinical condition. Moreover, hospital staff does not give much priority to patients with sepsis due to a lack of knowledge about sepsis being a medical emergency. Furthermore, in the US, the sepsis guidelines are considered as performance measures to evaluate the quality of the hospital accreditation or physician care, which is another reason for no compliance with these guidelines. Additionally, with the lack of standard protocols, there is a failure to communicate the risk and symptoms of sepsis between in-house hospital departments during clinical data exchange.

Read More in Detailed: https://www.marketsandmarkets.com/Market-Reports/sepsis-diagnostic-market-92673155.html

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sepsis Diagnostics Market: Opportunities & Challenges here

News-ID: 1867201 • Views: 122

More Releases from MarketsandMarkets

FinTech Blockchain Market Projected to reach $ 6,228.2 Million by 2023 | Key pla …
According to recent research "FinTech Blockchain Market by Provider, Application (Payments, Clearing, and Settlement, Exchanges and Remittance, Smart Contract, Identity Management, and Compliance Management/KYC), Organization Size, Vertical, and Region - Global Forecast to 2023", The FinTech blockchain market size is expected to grow from USD 370.3 Million in 2018 to USD 6,228.2 Million by 2023, at a Compound Annual Growth Rate (CAGR) of 75.9% during the forecast period. The key
Key Opportunities and Challenges in the C4ISR Market
The Command, Control, Communications, Computers, Intelligence, Surveillance & Reconnaissance (C4ISR) market was valued at USD 100.3 billion in 2017 and is projected to reach USD 119.39 billion by 2022, at a CAGR of 3.56% from 2017 to 2022. The objectives of this study are to analyze the C4ISR market along with the statistics from 2017 to 2022 as well as to define, describe, and forecast the C4ISR market on the
Blockchain in Insurance Market Ongoing Trends and Recent Developments | Key Play …
According to recent research "Blockchain In Insurance Market by Provider, Application (GRC Management, Death & Claims Management, Identity Management & Fraud Detection, Payments, and Smart Contracts), Organization Size (Large Enterprises and SMEs), and Region - Global Forecast to 2023", The blockchain in insurance market size is expected to grow from USD 64.5 million in 2018 to USD 1,393.8 million by 2023, at a Compound Annual Growth Rate (CAGR) of 84.9%
Chatbot Market Projected to reach $ 9.4 billion by 2024 | Key players include IB …
According to recent research "Chatbot Market by Component (Solutions and Services), Usage (Websites and Contact Centers), Technology, Deployment Model, Application (Customer Support and Personal Assistant), Organization Size, Vertical, and Region - Global Forecast to 2024", published by MarketsandMarkets, the global chatbot market size is expected to grow from USD 2.6 billion in 2019 to USD 9.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 29.7% during the

All 5 Releases


More Releases for Sepsis

05-16-2019 | Health & Medicine
Fact.MR
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report. Get Sample Copy of this Report @
Sepsis Diagnosis Market - Latest Trends, Forecast
Stratview Research announces the launch of a new research report on the Sepsis Diagnosis Market: By Technology (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), By Type of Testing (Blood Culture Media, and Instruments), By Mode of Testing (Automated, Semi-Automated), By Site of Testing (Laboratory Based, Patient Bed Side (POC)), By Type of Sepsis (Pathogen) (Bacterial, Fungal), By Testing Facility (Hospitals, Clinics, and Others), By Region (North America, Western Europe, Asia-Pacific,
Sepsis Diagnosis Market - Latest Trends, Forecast, and Opportunity Analysis
Stratview Research announces the launch of a new research report on the Sepsis Diagnosis Market: By Technology (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), By Type of Testing (Blood Culture Media, and Instruments), By Mode of Testing (Automated, Semi-Automated), By Site of Testing (Laboratory Based, Patient Bed Side (POC)), By Type of Sepsis (Pathogen) (Bacterial, Fungal), By Testing Facility (Hospitals, Clinics, and Others), By Region (North America, Western Europe, Asia-Pacific,
Sepsis Therapeutics Market: Regional Analysis by 2021
Sepsis is a serious medical condition that is characterized by an uncontrolled immune response to an infection and is a leading cause of mortality worldwide. This irresistible immune response of a patient is also known as Systemic Inflammatory Response Syndrome (SIRS). In severe cases of sepsis, the infection leads to a significant drop in blood pressure named as septic shock. The septic shock will instantaneously lead to failure of other
Sepsis Therapeutics Market; Key Trends and Opportunities
Sepsis, also known as septicemia, is a life-threatening disease caused when the body responds to an infection. Sepsis leads to a series of reactions that causes widespread inflammation throughout the body and could result in septic shock, a medical emergency. Sepsis is categorized by the presence of numerous bacteria in the blood that are actively dividing. These changes could lead to organ dysfunction such as depression of heart, collapse of
10-13-2017 | Health & Medicine
MDF
A Study on Sepsis Diagnostics Market
According to the report “Sepsis Diagnostics Market By Pathogen (Bacterial And Fungal), By Product (Instruments, Blood Culture Media, Assay Kits And Reagents), By Technology (Molecular Diagnostics, Microbiology, Immunoassay And Flow Cytometry), By Method (Conventional And Automated), By Usability (Laboratory And POC) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, the Global Sepsis Diagnostics Market was worth USD 370 million